From: Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
Thromboembolic event
n (%)
Total
1 (2.3)
Deep vein thrombosis
Pulmonary embolism
0
Myocardial infarction
Cerebral vascular accident
Arterial thrombosis of limb
Arterial thrombosis of mesenteries